3SBio Inc. and Isotechnika Pharma Inc. have announced the signing of a development and commercialization agreement for voclosporin, a next generation calcineurin inhibitor being developed for use in the prevention of organ rejection following transplantation and the treatment of autoimmune diseases. 3SBio will be responsible for the clinical development, registration and commercialization of voclosporin in China. Isotechnika will provide, under separate agreement, commercial supply to 3SBio on a cost-plus basis.

Read the full story here

A new study has indicated that endometriosis, in which cells from the lining of the uterus grow in other regions such as fallopian tubes and ovaries, can also be quickly and accurately identified by a small test. Researchers led by Ian Fraser at the University of Sydney and Maomar al-Jefout of Mu’tah University found that a small tissue sample taken from the uterine lining with a device inserted through the vagina works just as well. This condition of the uterus, which is linked to infertility, painful periods and pain during sexual intercourse, until now could only be detected through surgery.